istradefylline
istradefylline is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including NOURIANZ. Available dosage form: tablet, film coated.
Drug Details
- Generic Name
- istradefylline
- Brand Names
- NOURIANZ
- Application Number
- NDA022075
- Sponsor
- Kyowa Kirin, Inc.
- NDC Codes
- 2
- Dosage Forms
- TABLET, FILM COATED
- Routes
- ORAL
- Active Ingredients
- ISTRADEFYLLINE
Indications and Usage
1 INDICATIONS AND USAGE NOURIANZ is indicated as adjunctive treatment to levodopa/carbidopa in adult patients with Parkinson's disease (PD) experiencing "off" episodes. NOURIANZ is an adenosine receptor antagonist indicated as adjunctive treatment to levodopa/carbidopa in adult patients with Parkinson's disease (PD) experiencing "off" episodes ( 1 ).